Evidence map›Paper›PMID 35325716›Full record

ArticleBiosensors & bioelectronics2022

Longitudinal morphological and functional characterization of human heart organoids using optical coherence tomography.

Yixuan Ming, Senyue Hao, Fei Wang, Yonatan R Lewis-Israeli, Brett D Volmert, Zhiyao Xu, Anna Goestenkors, Aitor Aguirre, Chao Zhou

Abstract read
In one paragraph

Article in Biosensors & bioelectronics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Multiscale Construction, Evaluation, and Application of Organoids.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yixuan MingDepartment of Biomedical Engineering, Washington University in Saint Louis, USA.
Senyue HaoDepartment of Electrical & Systems Engineering, Washington University in Saint Louis, USA.
Fei WangDepartment of Biomedical Engineering, Washington University in Saint Louis, USA.
Yonatan R Lewis-IsraeliInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, USA; Department of Biomedical Engineering, College of Engineering, Michigan State University, USA.
Brett D VolmertInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, USA; Department of Biomedical Engineering, College of Engineering, Michigan State University, USA.
Zhiyao XuDepartment of Biomedical Engineering, Washington University in Saint Louis, USA.
Anna GoestenkorsDepartment of Biomedical Engineering, Washington University in Saint Louis, USA.
Aitor AguirreInstitute for Quantitative Health Science and Engineering, Division of Developmental and Stem Cell Biology, Michigan State University, USA; Department of Biomedical Engineering, College of Engineering, Michigan State University, USA.
Chao ZhouDepartment of Biomedical Engineering, Washington University in Saint Louis, USA. Electronic address: chaozhou@wustl.edu.

Funding

Oxylipin Signaling in Congenital Heart DiseaseR01HL151505 · NHLBI · MICHIGAN STATE UNIVERSITY · PI AGUIRRE, AITOR · 2021 to 2025
$2.2M
High-throughput integrated live imaging and optogenetic pacing platform to assess hypoxia responsiveness in the fly heartR01HL156265 · NHLBI · WASHINGTON UNIVERSITY · PI ZHOU, CHAO · 2021 to 2024
$2.1M
High throughput optical coherence tomography (OCT)-based imaging platform for label-free, non-invasive characterization of 3D tumor spheroids.R01EB025209 · NIBIB · WASHINGTON UNIVERSITY · PI ZHOU, CHAO · 2017 to 2021
$1.4M
Lipid signaling in cardiac development and diseaseK01HL135464 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AGUIRRE, AITOR · 2017 to 2021
$795k
NHLBI NIH HHS K01 HL135464NHLBI NIH HHS R01 HL151505NHLBI NIH HHS R01 HL156265NIBIB NIH HHS R01 EB025209
6 · The paper itself

Abstract

Organoids play an increasingly important role as in vitro models for studying organ development, disease mechanisms, and drug discovery. Organoids are self-organizing, organ-like three-dimensional (3D) cell cultures developing organ-specific cell types and functions. Recently, three groups independently developed self-assembling human heart organoids (hHOs) from human pluripotent stem cells (hPSCs). In this study, we utilized a customized spectral-domain optical coherence tomography (SD-OCT) system to characterize the growth of hHOs. Development of chamber structures and beating patterns of the hHOs were observed via OCT and calcium imaging. We demonstrated the capability of OCT to produce 3D images in a fast, label-free, and non-destructive manner. The hHOs formed cavities of various sizes, and complex interconnections were observed as early as on day 4 of differentiation. The hHOs models and the OCT imaging system showed promising insights as an in vitro platform for investigating heart development and disease mechanisms.

Indexed as

Biosensing TechniquesPluripotent Stem CellsCell DifferentiationHumansOrganoidsTomography, Optical CoherenceChambersHeart organoidshPSCOptical coherence tomography

Identifiers

PMID35325716
PMCPMC9713770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.